Home/Pipeline/AKG‑RSV‑VAX

AKG‑RSV‑VAX

Respiratory syncytial virus vaccine

PreclinicalActive

Key Facts

Indication

Respiratory syncytial virus vaccine

Phase

Preclinical

Status

Active

Company

Akagera Medicines

About Akagera Medicines

Rwanda‑based biotech delivering liposomal long‑acting injectables for TB and infectious disease vaccines.

View full company profile

Therapeutic Areas

Infectious Diseases Vaccines